M
Marcela Ot’alora G.
Publications - 4
Citations - 408
Marcela Ot’alora G. is an academic researcher. The author has contributed to research in topics: Randomized controlled trial & Clinical endpoint. The author has an hindex of 3, co-authored 3 publications receiving 105 citations.
Papers
More filters
Journal ArticleDOI
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study
Jennifer M. Mitchell,Michael P. Bogenschutz,Alia Lilienstein,Charlotte Harrison,Sarah Kleiman,Kelly Parker-Guilbert,Marcela Ot’alora G.,Wael Garas,Casey Paleos,Ingmar Gorman,Christopher R. Nicholas,Michael C. Mithoefer,Shannon Carlin,Bruce Poulter,Ann T Mithoefer,Sylvestre Quevedo,G. M. Wells,Sukhpreet S. Klaire,Bessel A. van der Kolk,Keren Tzarfaty,Revital Amiaz,Ray Worthy,Scott Shannon,Joshua D. Woolley,Cole Marta,Yevgeniy Gelfand,Emma Hapke,Simon Amar,Yair Wallach,Randall Brown,Scott Hamilton,Julie B. Wang,Allison R. Coker,Rebecca Matthews,Alberdina de Boer,Berra Yazar-Klosinski,Amy Emerson,Rick Doblin +37 more
TL;DR: A randomized, double-blind, randomized, placebo-controlled, multi-site phase 3 clinical trial (NCT03537014) was conducted to test the efficacy and safety of 3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy for the treatment of patients with severe PTSD, including those with common comorbidities such as dissociation, depression, a history of alcohol and substance use disorders, and childhood trauma as discussed by the authors.
Journal ArticleDOI
3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial.
Marcela Ot’alora G.,Jim Grigsby,Bruce Poulter,Joseph W Van Derveer,Sara Gael Giron,Lisa Jerome,Allison A. Feduccia,Scott Hamilton,Berra Yazar-Klosinski,Amy Emerson,Michael C. Mithoefer,Rick Doblin +11 more
TL;DR: The findings of this pilot dose response trial support previous investigations of MDMA-assisted psychotherapy as an innovative, efficacious treatment for posttraumatic stress disorder.
Journal ArticleDOI
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for victims of sexual abuse with severe post-traumatic stress disorder: an open label pilot study in Brazil
Alvaro V. Jardim,Dora V. Jardim,Bruno Daniel Rasmussen Chaves,Matheus Souza Steglich,Marcela Ot’alora G.,Michael C. Mithoefer,Dartiu Xavier da Silveira,Luís Fernando Tófoli,Sidarta Ribeiro,Rebecca Matthews,Rick Doblin,Eduardo Ekman Schenberg +11 more
TL;DR: Considering the current limitations in safe and efficacious treatments for PTSD and recent studies abroad with larger patient samples, MDMA-assisted psychotherapy could become a viable treatment in Brazil.
Journal ArticleDOI
MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.
Jennifer M. Mitchell,Michael P. Bogenschutz,Alia Lilienstein,Charlotte Harrison,Kelly S. Parker-Guilbert,Marcela Ot’alora G.,W. F. Garas,Casey Paleos,Ingmar Gorman,Michael C. Mithoefer,Shannon Carlin,Bruce Poulter,Ann T Mithoefer,Sylvestre Quevedo,Gregory Wells,Sukhpreet Klaire,Bessel A. van der Kolk,Keren Tzarfaty,Revital Amiaz,Ray Worthy,Scott Shannon,Joshua D. Woolley,Cole J. Marta,Emma Hapke,Simon Amar,Yair Wallach,Randall Brown,Scott Hamilton,Julie B. Wang,Allison R. Coker,Rebecca Matthews,A. de Boer,Berra Yazar-Klosinski,Amy Emerson,Rick Doblin +34 more
TL;DR: In this paper , a randomized, double-blind, placebo-controlled, multi-site phase 3 clinical trial (NCT03537014) was conducted to test the efficacy and safety of 3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy for the treatment of patients with severe PTSD.